Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 061828/0528 | |
| Pages: | 12 |
| | Recorded: | 11/18/2022 | | |
| Attorney Dkt #: | NCIP.P0105US/1001234029 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
17999337
|
Filing Dt:
|
11/18/2022
|
|
Publication #:
|
|
Pub Dt:
|
06/15/2023
| | | | |
|
Title:
|
NOVEL COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING SAME FOR TREATING OR PREVENTING NEURAL DAMAGE, NEURAL DISEASE, OR DEVELOPMENTAL DISORDER THROUGH PROMOTING PROLIFERATION, DIFFERENTIATION, AND/OR REGENERATION OF NEURAL CELLS
|
|
|
Assignees
|
|
|
|
|
| BIJEU-DONG 505-HO, 124, SAGIMAKGOL-RO, JUNGWON-GU |
| GYEONGGI-DO |
| SEONGNAM-SI, KOREA, REPUBLIC OF 13207 |
|
|
|
|
|
| 80, DAEHAK-RO, BUK-GU |
| DAEGU, KOREA, REPUBLIC OF 41566 |
|
|
Correspondence name and address
|
| |
NORTON ROSE FULBRIGHT US LLP
|
| |
98 SAN JACINTO BOULEVARD
|
| |
AUSTIN, TX 78701
|
Search Results as of:
05/30/2024 07:13 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
